Compare DNA & RGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DNA | RGR |
|---|---|---|
| Founded | 2008 | 1949 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Ordnance And Accessories |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 520.6M | 601.9M |
| IPO Year | 2020 | 1994 |
| Metric | DNA | RGR |
|---|---|---|
| Price | $6.53 | $37.60 |
| Analyst Decision | Hold | Strong Buy |
| Analyst Count | 2 | 1 |
| Target Price | $8.50 | ★ $43.00 |
| AVG Volume (30 Days) | ★ 978.2K | 99.9K |
| Earning Date | 05-07-2026 | 05-06-2026 |
| Dividend Yield | N/A | ★ 1.07% |
| EPS Growth | ★ 46.49 | N/A |
| EPS | N/A | ★ 0.44 |
| Revenue | $170,155,000.00 | ★ $546,057,000.00 |
| Revenue This Year | N/A | $2.38 |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $85.09 |
| Revenue Growth | N/A | ★ 1.94 |
| 52 Week Low | $5.37 | $28.33 |
| 52 Week High | $17.58 | $48.21 |
| Indicator | DNA | RGR |
|---|---|---|
| Relative Strength Index (RSI) | 33.04 | 43.73 |
| Support Level | $6.21 | $36.70 |
| Resistance Level | $7.38 | $38.95 |
| Average True Range (ATR) | 0.55 | 1.00 |
| MACD | -0.15 | -0.05 |
| Stochastic Oscillator | 0.63 | 13.93 |
Ginkgo Bioworks Holdings Inc is the platform for cell programming, providing flexible, end-to-end services that solve challenges for organizations across diverse markets, from food and agriculture to pharmaceuticals to industrial and specialty chemicals. The Company reorganized its operations into two operating and reportable segments: Cell Engineering engaged in providing biological R&D services for customers across a range of industries and Biosecurity that provides services to government and commercial customers to identify, monitor, prevent, mitigate, and ultimately protect humanity from biological threats. The maximum of revenue is from Cell Engineering Segment.
Sturm Ruger & Co Inc and its subsidiary are principally engaged in the design, manufacture, and sale of firearms to domestic customers. The company's design and manufacturing operations are in the United States, and almost all product content is domestic. The company has two reportable operating segments: firearms and castings. The firearms segment manufactures and sells rifles, pistols, and revolvers principally to a number of federally-licensed, independent wholesale distributors located in the United States. The castings segment manufactures and sells steel investment castings and metal injection molding parts. It generates maximum income from the sale of Firearms.